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Tetradenia riparia plant is used as a traditional medicine in Africa for the treatment of inﬂammatory and
infectious diseases as like parasitic. Therapy for leishmaniasis caused by Leishmania (Leishmania) ama-
zonensis specie often fails, and the conventional drugs are toxic, expensive, require a long period of
treatment, and adverse effects are common. The alternative therapies using natural products are inex-
pensive and have few or any adverse reaction. These reasons are sufﬁcient to investigate the new natural
therapeutic for leishmaniasis. We evaluated the potential of the essential oil (TrEO) and 6,7-
dehydroroyleanone (TrROY) isolated from T. riparia on L. (L.) amazonensis promastigote and amastigote
forms, cytotoxicity on human erythrocytes and murine macrophages, nitric production and inducible
nitric oxide synthase (iNOS) mRNA expression. TrEO was the most effective to promote the Leishmania
promastigote death. After 72 h incubation, the lethal dose of TrEO and TrROY that promoted 50%
Leishmania death (LD50) were 0.8 mg/mL and 3 mg/mL, respectively. TrEO and TrROY were not cytotoxic to
human erythrocytes, but TrROY was toxic to murine macrophages resulting in a low selectivity index. The
transmission electronic microscopy showed that TrEO (0.03 mg/mL) was able to modify the promastigote
ultrastructures suggesting autophagy as chromatin condensation, blebbing, membranous proﬁles and
nuclear fragmentation. Infected-macrophages treated with TrEO (0.03 mg/mL) or TrROY (10 mg/mL) had
an infection index decreased in 65 and 48%. TrEO did not induce iNOS mRNA expression or nitrite
production in macrophages infected with Leishmania. TrROY and mainly TrEO promoted the Leishmanias Clínicas e Biomedicina, Av
Laboratorio de Ensino e Pes-
Maringa , Parana , Brazil.
emarchi).
I.G. Demarchi et al. / Experimental Parasitology 157 (2015) 128e137 129death, and TrROY showed loss toxicity to erythrocytes cells. Other compounds derived from T. riparia and
the essential oil could be explored to develop a new alternative treatment for leishmaniasis.
© 2015 Elsevier Inc. All rights reserved.Fig. 1. Structural formula of compound 6,7-dehydroroyleanone derived from T. riparia
(TrROY).1. Introduction
Tetradenia riparia (Hochstetter) Codd plant belongs to the
Lamiaceae family, also known as Iboza riparia and Moschosma
riparium. It is used as a traditional medicine in Africa for the
treatment of inﬂammatory and infectious diseases. The plant is an
herbaceous shrub that occurs throughout tropical Africa and other
regions of the world (Polya, 2003; Shale et al., 1999; van Puyvelde
et al., 1988; York et al., 2011, York et al., 2012). In Brazil, it is
known as false myrrh, and it is mainly used as an ornamental plant
and incense (Gazim et al., 2010; Martins, 2008). Its leaves and
essential oil have been used for the treatment of malaria, crypto-
coccosis, candidiasis, and respiratory infections (Campbell et al.,
1997; Okem et al., 2012; van Puyvelde et al., 1986; York et al.,
2012). Natural products are relatively inexpensive, accessible, and
sustainable, and many of them do not have a high likelihood of
causing serious adverse effects (Adebayo, 2013).
Since 1940, leishmaniasis has been treated with antimonials
such as glucantime, but therapy often fails, and adverse effects are
frequently observed. Leishmania (Leishmania) amazonensis is the
etiologic agent of cutaneous and diffuse cutaneous leishmaniasis,
the most severe and destructive clinical form of the disease. This
species of parasite is also associated with therapeutic failure and
disease recurrence (WHO, 2010). For these reasons, researchers
have investigated natural products to discover new therapeutic
strategies for leishmaniasis.
The essential oil from T. riparia (TrEO) is a complex mixture of
terpenoids, including monoterpenes, sesquiterpenes, and diter-
penes (hydrocarbons or oxygenated), the most representative class
(Gazim et al., 2010). T. riparia is known as false myrrh and has
been used as traditional medicine also known as indigenous or
folk medicine used by lay people, but few studies have evaluated
its biological effects (Campbell et al., 1997; Cardoso et al., 2011;
Gazim et al., 2010, Gazim et al., 2011, Gazim et al., 2013;
Martins, 2008; van Puyvelde et al., 1988; Van Puyvelde et al.,
1987; van Puyvelde et al., 1986). Commiphora myrrh (Nees) Engl.
is real myrrh and has emerged as a good source of traditional
medicine for the treatment of inﬂammation, obesity, arthritis,
microbial infections, wounds, and pain in Africa, Arabia, and India.
The medicinal functions and usage of real myrrh are recorded in
ancient literature (Shen et al., 2012). The microbicidal and anti-
inﬂammatory activity of T. riparia has scarcely been documented
in the literature (Campbell et al., 1997; Gazim et al., 2010, Gazim
et al., 2013; Okem et al., 2012; York et al., 2011, York et al.,
2012). The diterpene 6,7-dehydroroyleanone isolated from T.
riparia (TrROY) may have some biological effects such as antioxi-
dant and antitermitic activity (Gazim et al., 2013; Kusumoto et al.,
2009). The leishmaniostatic activity of TrEO against L. (L.) ama-
zonensis were recently reported (Demarchi et al., 2013;
Thomazella et al., 2013), but this potential effects of TrEO and
then isolated compounds on Leishmania have not yet been
investigated. Therefore, to determine their potential as an alter-
native therapy for leishmaniasis, we studied TrEO and TrROY ef-
fects on L. (L.) amazonensis promastigote and amastigote forms,
cytotoxicity on human erythrocytes and murine macrophages,
nitric production and inducible nitric oxide synthase (iNOS) mRNA
expression.2. Materials and methods
2.1. Plant material
T. riparia leaves were collected monthly between September
2006 and August 2007 in Umuarama, Parana, Brazil (234602200S
and 531607300W, 391 m). The plant was identiﬁed by Professor
Ezilda Jacomasi of the Departamento de Farmacia of Universidade
Paranaense (UNIPAR, Umuarama, Parana, Brazil). A voucher spec-
imen of plant was deposited in the UNIPAR Herbarium (code
number 2502). The mean values for the maximum and minimum
temperatures, precipitation, and relative humidity from September
2006 to August 2007 were reported by Gazim et al. (Gazim et al.,
2010).2.2. Essential oil extraction of T. riparia
The fresh leaves of T. riparia were used to extract the essential
oil, which was obtained by hydrodistillation for 3 h using a
Clevenger-type apparatus. The distilled oils were collected and
dried over anhydrous sodium sulfate and stored in a freezer. The oil
was analyzed by gas chromatography-mass spectrometry (GCeMS)
using an Agilent 5973N GCeMS System that was operated in
electron ionization mode and equipped with a DB-5 capillary col-
umn (30 m  0.25 mm  0.25 mm, Agilent, PA, USA) that was used
to inject 1 ml of a solution sample (Gazim et al., 2010; Omolo et al.,
2004). The initial temperature of the columnwas 80 C. The column
was gradually heated to 260 CC at a rate of 4 C/min. The injector
(splitless, 0.5 min) and transfer line temperatures were held at
260 C and 280 C, respectively. Helium (1.0 mL/min) was used as a
carrier gas. The same temperature program was used for gas
chromatography with a ﬂame ionization detector (GC-FID). The
identiﬁcation of the compounds was based on comparisons of their
retention time that were obtained using various n-alkanes (C7 e
C25). Their electron impact mass spectra were compared with the
Wiley library spectra and literature (Gazim et al., 2010).
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Brieﬂy, the TrEO (2 g) from leaves was subjected to column
chromatography over a silica gel support and eluted with pentane,
pentane-dichloromethane (9:1; 8:2; 7:3 and 1:1), dichloro
methane-pentane (3:7), dichloromethane, dichloromethane-
methanol (9:1; 7:3 and 1:1), and methanol, resulting in 29 frac-
tions (Gazim et al., 2013). Fraction 17 (11.7 mg) pentane-
dichloromethane (8:2) were identiﬁed by 1H, 13C, DEPT, HSQC,
HMBC and NOESY according to Gazim et al. (2013) and by com-
parison with literature data. Fraction 17 orange crystalline powder
gave an {MH] e at m/z 313 was identiﬁed as TrROY (Fig. 1).
Spectral data corresponded with data previously described by
Kusumoto (Kusumoto et al., 2009).
2.4. Cytotoxicity assays
2.4.1. Hemolysis assay
Erythrocyte toxicity was determined as described by Valdez
et al. (Valdez et al., 2009). Brieﬂy, a 6% suspension of fresh deﬁ-
brinated human blood was prepared in sterile 1% glucose saline
solution. 6,7-dehydroroyleanone was dissolved in 5% dime-
thylsulfoxide (DMSO; obtained from Sigma-Aldrich, St. Louis, MO,
USA). DMSO concentration promoted hemolysis from 6% v/v, and at
5% did not cytotoxicity. The compoundwas then serially distributed
into culture plates at concentrations of 5.0e0.1 mg/mL for TrEO,
50e0.1 mg/mL for TrROY and 500e1 mg/mL for amphotericin B
(AmB, Anforicin, Cristalia Laboratory, S~ao Paulo, SP, Brazil). The
compounds were incubated with erythrocytes in suspension at
37 C. After 2 h, the samples were centrifuged at 300  g for 3 min.
Absorbance of the supernatant was determined at a wavelength
550 nm to estimate hemolysis. A solution of 4% Triton X-100 (Sig-
maeAldrich, St. Louis, MO, USA) was used as the positive control,
and the cell suspension was used as the negative control. The he-
molysis was tested in duplicate. The results are expressed as a
percentage of hemolysis based on the Hamolysis equation
(% ¼ 100  [(ApAs)/(ApAc)  100]; where Ap, As and Ac are the
absorbance of the positive control, test sample and negative con-
trol, respectively).
2.4.2. Macrophages cytotoxicity
Peritoneal macrophages were obtained from BALB/c mice in
accordance with the Ethics Committee on the Use of Experimental
Animals of the Universidade Estadual de Maringa, Parana State,
Brazil (warrant no.133/2012). The peritoneal cavity was washed
with 8 mL sterile RPMI 1640 medium. The cell suspension was
adjusted to 1 106 macrophages/mL. Next, 100 ml was plated in 96-
well culture plates (TPP, Switzerland). The plates were incubated
for 2 h at 37 C, 5% CO2, and non-adherent cells were removed by
sterile phosphate buffered saline (PBS) washing. TrROY was diluted
in DMSO and RPMI 1640 medium from 100 to 0.1 mg/mL, and TrEO
from 3 mg/mL to 30 ng/mL. The DMSO did not exceed 0.005% v/v,
and it had not macrophage cytotoxicity effect. Non-treated cultures
were used as viability control. The plates were maintained at 37 C
in a humid atmosphere containing 5% CO2 during 24 h. The results
were revealed using colorimetric cell viability XTT (2,3-bis[2-
methyloxy-4- nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxa
nilide) (Sigma Chemical Co; St. Louis, MO) (El-On et al., 2009;
Williams et al., 2003). A XTT solution (500 mg/mL) was activated
with 50 mg/mL phenazine methosulfate (PMS, Sigma Co Chemical;
St. Louis, USA), and it was added over the cell monolayer to each
well. After 3e5 h incubated at 37 C, with 5% CO2 and protected
from light, the result was measured at a wavelength 450/650 nm
using a spectrophotometer plate reader (ASYS Expert Plus, ASYS
Hitech GMBH, Austria). The cytotoxicity concentration (CC50) wasdeﬁned as the dose of the compound that reduced 50% of the
survival of macrophages comparing with untreated macrophages
(viability control) (Cardoso et al., 2011). This test was done in
duplicate.
2.5. Promastigote assay
2.5.1. Parasite strain and culture
L. (L.) amazonensis (MHOM/BR/1977/LTB0016) infection was
induced by inoculating the left footpad of BALB/c mice with 1 107
parasites. Animals between 30 and 40 days of agewere infected and
after 30 days, theywere sacriﬁced with 160mg/kg ketamine (Agner
Uni~ao, Embu-Guaçu, SP, Brazil) and 50mg/kg xylazine (Coopazine®,
Invervet Schering-Plough, Cotia, SP, Brazil). The lymph node frag-
ments were incubated in 199 culture medium supplemented with
10% fetal bovine serum, 1% human urine, 2 mM L-glutamine, and
antibiotics (100 UI/mL penicillin and 0.1 mg/mL streptomycin). The
cultures were incubated at 25 C, and parasites were maintained by
weekly transfers in 25 cm2 culture ﬂasks supplemented with 199
culture medium (Demarchi et al., 2012).
2.5.2. XTT tetrazolium method
Promastigote viability was evaluated using the XTT method.
Promastigotes (4  106 parasites/100 ml/well) from a logarithmic
growth phase culture were seeded into ﬂat-bottomed 96-well
plastic tissue culture microplates in triplicate. TrEO, TrROY, and
AmB were dissolved in 1.6% v/v DMSO in the ﬁrst well and diluted
in series from 50 mg/mL to 1 ng/mL in a 96-well culture plate. After
24, 48, and 72 h incubation at 25 C, 0.2 mg/mL XTT and 200 mM
phenazine methosulfate (PMS, Sigma Co Chemical; St. Louis, USA)
were added to each well and incubated for 3e5 h at 37 C. The
result was measured at a wavelength 450/650 nm using a spec-
trophotometer plate reader (ASYS Expert Plus, ASYS Hitech GMBH,
Austria). The lethal dose (LD50) was deﬁned as the dose of the
essential oil that reduced the survival of Leishmania parasites by
50% compared with untreated parasites (El-On et al., 2009;
Williams et al., 2003). The therapeutic selectivity index
(TSI ¼ CC50/LD50) was calculated by ratio of toxicity to macrophage
vs. toxicity to the parasites after 24 h incubation. The test was done
in triplicate.
2.5.3. Promastigote growth inhibition
Promastigotes were cultured in Schneider's insect medium
(SigmaeAldrich, St. Louis, MO, USA), pH 7.2, supplemented with
10% FCS (v/v) and 2 mM L-glutamine until they reached the loga-
rithmic growth phase. TrEO and TrROY were diluted in DMSO from
50 mg/mL to 1 ng/mL on a cell culture plate with 96 wells (TPP® test
plate, Switzerland). The concentrations of DMSO not exceed 1.6% v/
v DMSO in the ﬁrst well, and it had no effect on the parasites. Next,
100 ml of the suspension containing 4  106 parasites/mL was
distributed in each well of the culture plate. After 24 h at 25 C, an
aliquot of each well was added to a solution containing 10% eosin
and 2% formalin, and the parasites were counted in a Neubauer
chamber. All tests were performed in triplicate. The inhibitory
concentration that caused a 50% decrease in survival (IC50) of
promastigotes was calculated. Values were compared to promas-
tigotes cultures not treated. The results were evaluated by linear
regression of the inhibition percentage (Demarchi et al., 2012). The
selectivity index (SI ¼ CC50/IC50) was calculated by ratio of toxicity
concentration to macrophage vs. inhibitory concentration to the
parasite growth after 24 h incubation.
2.5.4. Ultrastructural alterations
L. (L.) amazonensis promastigotes were grown in 199 medium
during 3 days in 25 cm2 culture vials at 25 C. The LD50
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(IC50 ¼ 30 ng/mL) (Thomazella et al., 2013) was added to the cul-
tures and incubated at 25 C for 24 h. After incubation, the IC50 was
calculated according to the number of remaining parasites in a
Neubauer chamber compared with control cultures without drugs
and diluents (DMSO). The results were evaluated by linear regres-
sion of the inhibition percentage. An untreated culture was used as
a negative control, and the ultrastructural changes were observed
by transmission electron microscopy. For this, the samples were
centrifuged at 12,000 g-force per minute for 10 min and ﬁxed in
Karnovsky solution 2% paraformaldehyde, 2.5% glutaraldehyde in
0.1 M cacodylate buffer, pH 7.2 at 4 C (Karnovsky, 1965). The ma-
terial was ﬁxed in 2% osmium tetroxide in 0.1 M cacodylate buffer
for 1 h. Block staining was performedwith 2% uranyl acetate for 2 h,
and the blocks were dehydrated in a graded series of alcohol and
acetone. Embedding was performed in Epon 812 resin (Luft, 1961).
Sections were obtained using an Sorval Porter Blum MT-2 ultra-
microtome and concentrated in 2% uranyl acetate (Watson, 1958)
and nitrate/acetate lead (Reynolds, 1963). The JEOL 1200EX II
transmission electron microscopy was used for ultrastructural
evaluation. The assays were conducted in duplicate.
2.6. Amastigote assay
2.6.1. Leishmania infection on macrophages to obtain amastigote
forms
Peritoneal macrophages were obtained from BALB/c mice peri-
toneal cavity as already reported above. The cell suspension was
adjusted to 1 106 macrophages/mL. Next, 500 mL were distributed
on 13 mm-diameter sterile glass coverslips (Glastecnica, S~ao Paulo,
SP, Brazil), and placed in 24-well culture plates (TPP, Switzerland).
The plates were incubated for 2 h at 37 C. The non-adherent cells
were removed by sterile PBS washing. Macrophages were infected
with promastigote forms in the proportion of six parasites for each
macrophage, and the plates were incubated for 4 h at 37 C in an
atmosphere of 5% CO2.
2.6.2. Infection index
TrEO and TrROY were diluted in DMSO and RPMI 1640 medium.
The ﬁnal concentration of DMSO did not exceed 0.05%, and no
cytotoxicity effect on the macrophages was observed. TrEO and
TrROY were added to cultures at concentrations from 300 mg/mL to
30 ng/mL, and 100 to 0.1 mg/mL, respectively. After 24 h at 37 C and
5% CO2, the cells on coverslips were ﬁxed in 95% ethanol and dyed
with eosin and hematoxylin. At least 200 cells were counted in an
optical microscope. To infection index was determined from the
percentage of infected macrophages multiplied by the mean
number of parasites per macrophage. The supernatant was stored
at - 30 C to nitrite assay.
2.7. Inducible nitric oxide synthase (iNOS) expression and nitrit
assay
2.7.1. Cells and treatment
Peritoneal macrophages were obtained from BALB/c mice.
Brieﬂy, the peritoneal cavity was washed with 8 mL sterile RPMI
1640 culture medium. The cell suspension was adjusted to 1  106
macrophages/mL, 1 mL of which was added to each well of a 12-
well culture plate. The plates were incubated for 1 h at 37 C, and
non-adherent cells were removed by three sterile washes in PBS.
The adherent cells were incubated in RPMI 1640 culture medium.
After a few minutes, macrophages were subjected to the following
conditions: (1) stimulated with 5 mg/mL lipopolysaccharide (LPS,
SigmaeAldrich, Brazil), (2) untreated and uninfected (negative
control), (3) infected by the promastigote form of L. (L.) amazonensisat a proportion of six parasites for each macrophage, (4) treated
with 30 ng/mL TrEO, (5) infected with the promastigote form of L.
(L.) amazonensis for 4 h and treated with 30 ng/mL TrEO, (6) treated
with 100e0.1 mg/mLTrROY, (7) infectedwith the promastigote form
of L. (L.) amazonensis for 4 h and treatedwith 100e1 mg/mLThe ﬁnal
concentration of DMSO did not exceed 0.01%, and no cytotoxic ef-
fect on themacrophages was observed. The plates were maintained
at 37 C in a humid atmosphere that contained 5% CO2 for 3, 6, and
24 h. The supernatant was also removed and stored at 30 C for
the nitrite assay. Trizol reagent (Invitrogen, Carlsbad, CA, USA) was
added to adhered cells for RNA extraction.
2.7.2. Nitrite assay
Nitric oxide was quantiﬁed by determining the accumulation of
nitrite (NO2) in the supernatants after 24, 48, and 72 h using the
standard Griess assay (Green et al., 1982). Readings were performed
in a spectrophotometer at a wavelength 550/620 nm (ASYS Expert
Plus, ASYS Hitech GMBH, Austria). The experiments were per-
formed in duplicate and on different days. The results are expressed
as nitrite concentration (mM).
2.7.3. mRNA analysis by semi-quantitative reverse transcriptase-
polymerase chain reaction (RT-PCR)
RNA from the samples that were stored in Trizol reagent was
extracted according to the manufacturer. cDNA was synthesized
using 1 mg of total RNA as a template in a reverse transcription
reaction (Superscript III reverse transcriptase, Invitrogen, Carlsbad,
CA, USA). RNA quantiﬁcation (ng/ml) and the determination of pu-
rity were performed using NANODROP 2000 UVeVis Spectropho-
tometer (Thermo Fisher Scientiﬁc Inc, USA), considering an optimal
purity level  1.8. PCR primers were: iNOS (Genbank accession no.
NM_010927.3, forward 50-CTGCAGCACTTGGATCAGGAACTG-30;
reverse 50-GGGAGTAGCCTGTGTGCACCTGGAA-30, 311 bp);
Glyceraldehyde-3 phosphate dehydrogenase (GAPDH) mRNA of
Mus musculus was used as intern control (Genbank accession no.
XM_001476707.3, forward 50-CCACCATGGAGAAGGCTGGGGCTC-30;
reverse 50-AGTGATGGCATGGACTGTGGTCAT-30, 239 bp). The
primers were chosen according to the BLAST tool (available in the
Genbank database) and previous publications (Byrne et al., 2011;
Chen et al., 2004). The PCR conditions were the following: 95 C
(5 min), 30 cycles of 95 C (20 s) and 55 C (25 s), followed by a
standard denaturation curve. iNOSmRNA expressionwas evaluated
by comparing the presence and absence of the expression between
experimental conditions and incubation times. Semi-quantitative
RT-PCR was conducted by quantifying the densitometry of the
bands using ImageJ software (National Institutes of Health, USA).
Each gene was normalized to GAPDH as a housekeeping gene (in-
ternal control) (Lee et al., 2011). The ampliﬁed DNA fragments were
separated by 2% agarose gel electrophoresis and revealed with
ethidium bromide in a transilluminator.
2.8. Statistical analysis
The values are presented as mean ± standard error of mean
(SEM). Differences among means and values were tested for sta-
tistical signiﬁcance using one-way analysis of variance (ANOVA)
and the Tukey test. Analyses were performed using Statistic 7
software. Values of p < 0.05 were considered statistically
signiﬁcant.
3. Results and discussion
The essential oil and 6,7-dehydroroyleanone derived from T.
riparia induced Leishmania promastigote forms death (Fig. 2). After
24, 48, and 72 h incubation, the LD50 of T. riparia essential oil was
Fig. 2. Antileishmanial activity and hamolysis percentage of TrEO and TrROY. Leishmania promastigotes were incubated under the following conditions for 24, 48, and 72 h: (A)
TrEO. (B) TrROY. (C) AmB (leishmaniasis reference drug). The lethality percentage was obtained using the XTT method. (D) Hamolysis percentage of TrEO (5.0e0.3 mg/mL) in
erythrocytes. (E) Haemolysis percentage in erythrocytes treated with TrROY (50.0e0.2 mg/mL). (F) Haemolysis percentage of AmB (500e1 mg/mL) in erythrocytes. Each experiment
was performed independently and in triplicate.
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16.9, 14.9, and 3 mg/mL (Fig. 2B), respectively. LD50 AmB was less
than 1.5 mg/mL in all times (Fig. 2C). No difference was found be-
tween LD50 of TrEO and AmB (p> 0.05). TrROY LD50 was higher than
AmB and TrEO (p < 0.001). Thus, TrEO had better microbicidal ac-
tivity TrROY.
Essential oils are natural products that contain a complex
mixture of pharmacological compounds. These compounds are
most often terpenoids, which are hydrocarbons. The chemical
composition of TrEO was analyzed by GCeMS in Gazim et al. (2010)
showing the chemical identiﬁcation and concentration (%) of
compounds isolated from TrEO. The chemical composition revealed
a complex terpenoids mixture such as diterpenes, sesquiterpenes
and monoterpenes (Gazim et al., 2010) with anti-inﬂammatory
activity and microbicidal effects (Campbell et al., 1997; Gazim
et al., 2010, Gazim et al., 2013; Okem et al., 2012; York et al., 2011,
York et al., 2012). Antileishmanial activity of TrEO and isolatedsubstances from this plant has been poorly described (Torquilho
et al., 1999; Thomazella et al., 2013). Thus, the substances with
anti-Leishmania activity until remain unknown. We showed that a
diterpene TrROY from TrEO is one of the substances with anti-
leishmanial activity. Other substances isolated from TrEO should be
evaluated against Leishmania, and also interactions between iso-
lated compounds could be performed to identify the substances
with anti-Leishmania activity. The several biological effects of
essential oils can be explained by the interactions between
different bioactive components may lead to synergistic, additive, or
antagonistic effects.
The use of compound isolated from essential oils may not have
the same effect promoted by essential oil requiring a greater
amount of isolated to achieve the desired action (Bassole and
Juliani, 2012). These reasons may explain the highest concentra-
tion of the isolated compound that was necessary to induce
Leishmania death compared with TrEO. Checkerboard, graphical
Table 1
Antileishmanial and macrophage cytotoxicity effects of 6,7-dehydroroyleanone and the essential oil derived from Tetradenia riparia.
Treatment Promastigote
IC50/24 h (mg/mL)
Promastigote LD50/24 h
(mg/mL)
Murine macrophage
cytotoxicity CC50/24 h (mg/mL)
Selectivity index (SI) Therapeutic selectivity
index (TSI)
6,7-dehydroroyleanone 2.45 16.9 0.53 0.22 0.03
T. riparia essential oil 0.03 0.5 0.17 5.67 0.34
IC50 ¼ inhibitory concentration that reduces 50% parasite growth; LD50 ¼ 50% lethal dose; CC50 ¼ 50% cytotoxicity concentration; SI ¼ CC50/IC50; TSI ¼ CC50/LD50.
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these interactions (Bassole and Juliani, 2012), but we have not yet
assessed the interactions between essential oil components.
Terpenoids have antiparasitic effects on different Leishmania
species (Ogungbe and Setzer, 2013). Some diterpenoid compounds
that are isolated from plants have been reported to have leishma-
nicidal activity, particularly against L. amazonensis (Dos Santos
et al., 2011; Jullian et al., 2005; Santos et al., 2013), but the effectsFig. 3. Peritoneal macrophages of BALB/c mice infected and treated with TrEO and TrROY
infected with L. (L.) amazonensis (6 parasites/cell). (C) infected-macrophages treated with
infected-macrophages treated with 3 mg/mL of TrEO. (F) infected-macrophages treated with
Arrow indicates amastigote intracellular forms. All conditions were tested in duplicate andof the diterpene TrROY on this species had not yet been demon-
strated. Some studies showed that diterpenoids favor docking to
glycerol-3-phosphate dehydrogenase (GPDH) of L. mexicana
(Ogungbe and Setzer, 2013), which is also involved in the glyco-
somal and cytosolic glycolytic pathways of Leishmania (Zhang et al.,
2013). One of these pathways involves NADH that is produced by
GPDH, which can be evaluated using the XTT assay (Ramirez-
Macias et al., 2012). This method has been used to study the. (A) non-infected and non-treated macrophages (negative control). (B) macrophages
100 mg/mL of TrROY. (D) infected-macrophages treated with 0.1 mg/mL of TrROY. (E)
30 ng/mL of TrEO. The cells were stained with hematoxylin and eosin (100  objective).
analyzed after 24 h of the incubation at 37 C with 5% CO2.
Fig. 4. Transmission electron microscopy of L. (L.) amazonensis treated with TrEO for 24 h. (A) Leishmania promastigotes. (BeF) Promastigotes treated with TrEO (30 ng/mL). N,
nucleus; N*, abnormal chromatin condensation nuclear alterations; K, kinetoplast; M, mitochondria; FP, ﬂagellar pocket; F, ﬂagellum; V, vacuoles; LV, lipid vesicles; R, myelin-like
ﬁgure appears in close association with the ﬂagellar pocket membrane; *membranous proﬁles; **blebbing; #mitochondrial swelling.
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et al., 2009; Williams et al., 2003). We showed that the essential oil
and TrROY derived from T. riparia probably promote Leishmania
death through mitochondrial metabolism pathways.
TrEO at 5 mg/mL promoted 3.2% hamolysis in human erythro-
cytes (Fig. 2). TrROYexhibited low toxicity in human erythrocytes at
50 mg/mL (<18% hemolysis) comparing with reference drug (AmB,
50 mg/mL, > 50% hemolysis) (Fig. 2). Gazim et al. (2014) showed that
TrEO and TrROY were not cytotoxic to human melanoma, human
nervous system and human colon cells line. Although TrROY was
not toxicity on human cells, we observed a cytotoxicity of this
compound on murine macrophage (Table 1). TrROY CC50 was
0.53 mg/mL, and the selectivity index (SI) and therapeutic SI (TSI)
were 0.22 and 0.03, respectively. TrEO CC50 was 0.17 mg/mL)
resulting in 5.67 for SI and 0.34 for TSI. The TSI value obtained with
TrEO was ~11 folds higher concentration compared to observe with
TrROY (Table 1). The cytotoxicity effects on murine macrophages
can also be observed in Fig. 3.
TrEO at 30 ng/mL (IC50) and 0.5 mg/mL (LD50) inhibited 62% and
80% of Leishmania promastigote growth after 24 h, respectively.
Both concentrationsmodiﬁed themorphology of L. (L.) amazonensis
promastigote viewed by transmission electronic microscopy. The
ultrastructural changes observed with the IC50 included intense
cytoplasmvacuolization, membranous proﬁles inside the organelle,
lipid vesicles, and membrane blebbing that suggested autophagy,thickening of the kinetoplast, chromatin condensation, and nuclear
fragmentation (Fig. 4).
Nuclear fragmentation suggests apoptosis, and a vesicle that
engulfs a part of the cytoplasm indicates autophagic cell death. The
presence of multivesicular bodies and several vacuoles that have
membrane proﬁles and cellular debris is related to the presence of
secondary lysosomes and organelles that are likely involved in the
degradation of damaged structures (Rodrigues and de Souza, 2008;
Santos et al., 2013). They may also correspond to the secretion of
abnormal lipids that accumulate as consequence of drug treatment
and alterations in the physical properties of lipids and membranes,
leading to the accumulation of concentric membranes, and myelin-
like structures. The lipid composition can induce irreversible
changes in the structure and function of several organelles, leading
to the appearance of autophagosomes to remove and recycle
abnormal membrane structures and suggesting an intracellular
remodeling process (Granthon et al., 2007; Lira et al., 2001). TrEO
LD50 promoted the complete destruction of parasite membranes
and other structures. These results indicate the high potential of
this essential oil to induce L. (L.) amazonensis death.
Both TrEO and TrROY decreased the infection index of murine
macrophages infected with Leishmania amastigote signiﬁcantly.
While the infection index 177 was obtained in macrophages
infected and non-treated (positive control), TrEO index was 80 at
3 mg/mL, 73 (300 ng/mL) and 62 (30 ng/mL) reducing the infection
Fig. 5. iNOS mRNA expression using semi-quantitative RT-PCR. (A) DNA fragments
were separated in 2% agarose gel electrophoresis and revealed with ethidium bromide
in a transilluminator. (B) expression levels of iNOS mRNA were normalized to GAPDH
as a housekeeping gene (internal control). M, molecular marker; C-, intern negative
control (H2O). Cþ, DNA obtained from L. (L.) amazonensis promastigotes cultured in 199
medium during 3 days. LPS, lipopolysaccharide-stimulated macrophages; Control,
untreated and uninfected macrophages (negative control); LLa, macrophages infected
with L. (L.) amazonensis; TrEO, macrophages treated with 30 ng/mL of TrEO; LLa TrEO,
macrophages infected with L. (L.) amazonensis and treated with 30 ng/mL of TrEO. All
of the conditions were analyzed with 3, 6, and 24 h incubation at 37 C. *p < 0.05.
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0.1 mg/mL, 96 (1 mg/mL), 93 (10 mg/mL) and 105 (100 mg/mL)
decreasing in 31, 46, 48 and 41%, respectively. Thus, TrEO at 30 ng/
mL showed the most appropriate results because it has not pre-
sented toxicity into the cells and promoted promastigote and
amastigote forms death.
TrEO showed the outcome and shows promise in leishmaniasis
treatment. Recent research on essential oils has shown a successful
approach to obtain new antileishmanial alternatives (Monzote
et al., 2007). Studies have showed the promising results of the
essential oils from Chenopodium ambrosioide in BALB/c mice
Leishmania-infected (Monzote et al., 2009, Monzote et al., 2010,
Monzote et al., 2014, Monzote et al., 2007). The use of naturalproducts could be an alternative to cutaneous leishmaniasis ther-
apy, but there are few studies showing the effectiveness of essential
oils. Thus, TrEO and TrROY could be explored to develop a new
alternative treatment for leishmaniasis. We suggest that in vivo
studies should be performed to evaluate the therapeutic efﬁcacy of
essential oil and its compounds from T. riparia in cutaneous
leishmaniasis.
Some medicinal plants have anti-inﬂammatory effects and can
act on immune response, and it can be demonstrated by reductions
in iNOS expression and nitric oxide synthesis (Choudhari et al.,
2013; Jeong et al., 2013). The Leishmania genus survives in macro-
phages, and cellular death is induced by reactive oxygen species,
especially nitric oxide, which depends on iNOS expression (Amoo
et al., 2012; Oliveira et al., 2014). In our study, iNOS mRNA was
expressed by infected-macrophages after 3 and 6 h (Fig. 5A), and
the iNOS mRNA levels were higher in treated-macrophages than in
infected-macrophages, but infected-macrophage treated with TrEO
did not expressed iNOS (Fig. 5B). After 24 h, iNOS mRNA was
observed only in LPS-stimulated macrophages. The nitrite pro-
duction was <0.1 mM under all of the experimental conditions at 3
and 6 h. After 24 h, the nitrite level was 5 mM to LPS-stimulated
macrophages, 1.8 mM to treated-macrophages, 1.7 mM to infected
and treated-macrophages, while it was 0.8 mM to Leishmania-
infected cells (p < 0.001) comparingwith 1.5 mM to negative control
(only macrophage). Thus, the infection reduced nitrite levels but
did not inhibit iNOS mRNA expression in macrophages. These re-
sults is in concordance with studies that show the infection caused
by L. amazonensis can decrease the production of nitric oxide as an
escape mechanism of the immune host (Amoo et al., 2012; Oliveira
et al., 2014). TrROY also did not change the iNOS mRNA expression
and nitrite levels (1.8 mM) comparing with control.
This difference between iNOS mRNA expression and nitrite
production shows that the parasite affected post-transcriptional
nitric oxide synthesis events, it may result in parasite survival
and escape from the immune response. Calegari et al. (Calegari-
Silva et al., 2009) reported that L. amazonensis has developed an
adaptive strategy to escape from host defenses by activating the
host transcriptional response, particularly nuclear factor kB, which
in turn down regulates the expression of iNOSmRNA and favors the
infection. In addition, L. amazonensis produces nitric oxide, which
may lead to iNOS downregulation by macrophages (Balestieri et al.,
2002; Genestra et al., 2006). TrEO increased iNOS mRNA expres-
sion, but it did not change nitrite production as well its isolate
suggesting that TrEO did not act on iNOS and nitrite production
during Leishmania infection, but TrROY and TrEO can modulate
other immune mechanisms until not investigated.
Previous studies have shown the anti-inﬂammatory effects of T.
riparia extract on prostaglandins, cyclooxygenase 1 (COX 1), and
cyclooxygenase 2 (COX 2), but its effect on iNOS has been unknown
(Ndhlala et al., 2011; Okem et al., 2012). In leishmaniasis, this in-
crease in iNOS may inﬂuence the nitric oxide production and pro-
mote elimination of the parasite. TrEO did not affect this
mechanism but still acted against Leishmania. Other mechanisms of
the immune response are involved in Leishmania death such as a
balance of the cytokines of host immune response that could solve
the curse of infection (Amoo et al., 2012; Oliveira et al., 2014). The
main immunopathogenesis competencies of L. amazonensis are to
carry the anergic diffuse cutaneous leishmaniasis at the T-cell
hyposensitivity pole and with a higher Th2-type immune response.
This shift and imbalance in immunity leads to persistence of the
disease and treatment failure (Silveira et al., 2009). New drugs with
antileishmanial and immunomodulation activity may be promising
to treatment leishmaniasis, and TrEO can be one of this, and the
immunomodulatory effects of TrEO have been conducted by us.
Despite the African and other population have used this plant
I.G. Demarchi et al. / Experimental Parasitology 157 (2015) 128e137136for a variety diseases, the biological effects still remained to be
investigated. We showed in vitro that the TrEO and TrROY have an
ability to induce the Leishmania death by mitochondrial meta-
bolism pathways, and induction of the secretion of abnormal lipids
that accumulate as a consequence of drug treatment, and alter-
ations in the physical properties of lipids andmembranes. Although
the isolated showed a high cytotoxicity inmurinemacrophages, the
plant and the essential oil were not cytotoxicity against human
cells. The cytotoxicity of TrROY must be considered before thera-
peutic application in leishmaniases. Other compound isolated from
T. riparia may be investigated to the development of future leish-
manicidal agents. For this, in vivo studies and other cytotoxicity
assaysmust be conducted to ensure the safe use of this plant and its
compounds to infections or inﬂammatory diseases. The isolation of
antileishmanial compounds from the essential oil of T. riparia
supports the traditional medicinal use of this plant as a treatment
for parasitological infections as leishmaniasis.
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